Cite
Zhang XP, Chen XJ, Li BZ, et al. Active targeted Janus nanoparticles enable anti-angiogenic drug combining chemotherapy agent to prevent postoperative hepatocellular carcinoma recurrence. Biomaterials. 2022;281:121362doi: 10.1016/j.biomaterials.2022.121362.
Zhang, X. P., Chen, X. J., Li, B. Z., Xu, S., Wu, Z. L., Hu, M. G., Zhao, Z. M., Zhao, G. D., Wang, C. R., Hong, W., Li, S. P., Li, L., Wang, C. G., Nie, G., & Liu, R. (2022). Active targeted Janus nanoparticles enable anti-angiogenic drug combining chemotherapy agent to prevent postoperative hepatocellular carcinoma recurrence. Biomaterials, 281121362. https://doi.org/10.1016/j.biomaterials.2022.121362
Zhang, Xiu-Ping, et al. "Active targeted Janus nanoparticles enable anti-angiogenic drug combining chemotherapy agent to prevent postoperative hepatocellular carcinoma recurrence." Biomaterials vol. 281 (2022): 121362. doi: https://doi.org/10.1016/j.biomaterials.2022.121362
Zhang XP, Chen XJ, Li BZ, Xu S, Wu ZL, Hu MG, Zhao ZM, Zhao GD, Wang CR, Hong W, Li SP, Li L, Wang CG, Nie G, Liu R. Active targeted Janus nanoparticles enable anti-angiogenic drug combining chemotherapy agent to prevent postoperative hepatocellular carcinoma recurrence. Biomaterials. 2022 Jan 04;281:121362. doi: 10.1016/j.biomaterials.2022.121362. Epub 2022 Jan 04. PMID: 34998170.
Copy
Download .nbib